Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Di Raimondo

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Expert Opinion on Biological Therapy|May 22, 2009
Insights into defibrotide: an updated reviewF Morabito, M Gentile, F Gay, et al.
Bone Marrow Transplantation|May 7, 2003
G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatmentG Milone, S Leotta, F Indelicato, et al.
British Journal of Haematology|August 8, 1998
In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemiaF Morabito, C Stelitano, I Callea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?F Di Raimondo, L Caruso, G Bonanno, et al.
La Radiologia Medica|September 10, 2008
Cementoplasty in the management of painful extraspinal bone metastases: our experienceA Basile, G Giuliano, V Scuderi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMAF Mandelli, M C Petti, A Ardia, et al.
Leukemia|June 22, 2001
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosisF Di Raimondo, M P Azzaro, G A Palumbo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myelomaA Romano, A Chiarenza, U Consoli, et al.
Bone Marrow Transplantation|June 20, 2003
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by RituximabS Galimberti, F Guerrini, F Morabito, et al.
Annals of Hematology|July 31, 2015
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agentsA Romano, N L Parrinello, M L Consoli, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Expert Opinion on Biological Therapy|May 22, 2009
Insights into defibrotide: an updated reviewF Morabito, M Gentile, F Gay, et al.
Bone Marrow Transplantation|May 7, 2003
G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatmentG Milone, S Leotta, F Indelicato, et al.
British Journal of Haematology|August 8, 1998
In vitro drug-induced cytotoxicity predicts clinical response to fludarabine in B-cell chronic lymphocytic leukaemiaF Morabito, C Stelitano, I Callea, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?F Di Raimondo, L Caruso, G Bonanno, et al.
La Radiologia Medica|September 10, 2008
Cementoplasty in the management of painful extraspinal bone metastases: our experienceA Basile, G Giuliano, V Scuderi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
A randomised clinical trial comparing idarubicin and cytarabine to daunorubicin and cytarabine in the treatment of acute non-lymphoid leukaemia. A multicentric study from the Italian Co-operative Group GIMEMAF Mandelli, M C Petti, A Ardia, et al.
Leukemia|June 22, 2001
Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosisF Di Raimondo, M P Azzaro, G A Palumbo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 9, 2012
Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myelomaA Romano, A Chiarenza, U Consoli, et al.
Bone Marrow Transplantation|June 20, 2003
Quantitative molecular evaluation in autotransplant programs for follicular lymphoma: efficacy of in vivo purging by RituximabS Galimberti, F Guerrini, F Morabito, et al.
Annals of Hematology|July 31, 2015
Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agentsA Romano, N L Parrinello, M L Consoli, et al.
Pageof 6